Realbotix Corp.
XBOTF
$0.2551
-$0.0004-0.16%
| Weiss Ratings | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.48 | |||
| Price History | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.00% | |||
| 30-Day Total Return | -8.11% | |||
| 60-Day Total Return | 124.17% | |||
| 90-Day Total Return | 126.55% | |||
| Year to Date Total Return | 70.07% | |||
| 1-Year Total Return | 132.12% | |||
| 2-Year Total Return | 48.14% | |||
| 3-Year Total Return | -66.62% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -49.95% | |||
| 52-Week Low % Change | 299.22% | |||
| Price | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.51 | |||
| 52-Week Low Price | $0.06 | |||
| 52-Week Low Price (Date) | Oct 01, 2024 | |||
| 52-Week High Price (Date) | Jan 13, 2025 | |||
| Valuation | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 50.33M | |||
| Enterprise Value | 51.47M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | 0.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 25.51 | |||
| Price/Book (Q) | 5.51 | |||
| Enterprise Value/Revenue (TTM) | 26.05 | |||
| Price | $0.26 | |||
| Enterprise Value/EBITDA (TTM) | -44.48 | |||
| Enterprise Value/EBIT | -13.34 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 196.73M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (647) 578-7490 | |||
| Address | Bay Adelaide Centre – North Tower Toronto, ON M5H 0B4 | |||
| Website | www.realbotix.ai | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -195.24% | |||
| Profit Margin | -494.70% | |||
| Management Effectiveness | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -19.64% | |||
| Return on Equity | -- | |||
| Income Statement | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.61M | |||
| Total Revenue (TTM) | 1.98M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 153.50K | |||
| EBITDA (TTM) | -1.16M | |||
| EBIT (TTM) | -3.86M | |||
| Net Income (TTM) | -9.77M | |||
| Net Income Avl. to Common (TTM) | -9.77M | |||
| Total Revenue Growth (Q YOY) | 419.55% | |||
| Earnings Growth (Q YOY) | -62.90% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | -74.01% | |||
| Balance Sheet | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 930.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.32M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.07M | |||
| Current Ratio (Q) | 0.594 | |||
| Book Value Per Share (Q) | $0.05 | |||
| Total Assets (Q) | 12.75M | |||
| Total Current Liabilities (Q) | 2.23M | |||
| Total Debt (Q) | 2.11M | |||
| Total Liabilities (Q) | 3.68M | |||
| Total Common Equity (Q) | 9.11M | |||
| Cash Flow | XBOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 3.17M | |||
| Cash from Financing (TTM) | -452.50K | |||
| Net Change in Cash (TTM) | -2.05M | |||
| Levered Free Cash Flow (TTM) | -660.70K | |||
| Cash from Operations (TTM) | -4.77M | |||
